
Journal of Medicinal Chemistry p. 1962 - 1969 (1990)
Update date:2022-08-02
Topics:
Rosenberg, Saul H.
Woods, Keith W.
Sham, Hing L.
Kleinert, Hollis D.
Martin, Donald L.
et al.
Incorporation of nonreactive polar functionalities at the C- and N-termini of renin inhibitors led to the development of a subnanomolar compound (21) with millimolar solubility.This inhibitor demonstrated excellent efficacy and a long duration of action upon intravenous administration to monkeys.While activity was also observed intraduodenally, a comparison of the blood pressure responses indicated low bioavailability.Subsequent experiments in rats showed that, although the compound was absorbed from the gastrointrestinal tract, extensive liver extraction severely limited bioavailability.
View MoreChuzhou Baiao Biologhy S&T Co., Ltd.
Contact:+86-25-83212599;+86-25-83212699 13705185959
Address:Room 905, Tianzheng International Platza, No.399, Zhongyang Road ,Nanjing, Jiangsu Province, China
Nanjing Habo Medical Technology Co., Ltd.
Contact:025-85769882
Address:No.108. Ganjiabian east. Qixia District .Nanjing
HANGZHOU TOYOND BIOTECH CO., LTD
Contact:+86-571-86965177
Address:No. 189, Fengqi East Road, Hangzhou, China
Chengdu Boon Stream Chemical Industry Co.,Ltd.
Contact:+86-28-83156758
Address:No.859,Dongzikou Road,Jinniu District,Chengdu,Sichuan,P.R.China
website:http://www.chemdow.com
Contact:0086-10-82435335
Address:Room 401,Unit 3,4th Floor,Shangdijiayuan,Shangdi East Road, Haidian District,Beijing
Doi:10.1007/s11172-013-0117-y
(2013)Doi:10.1016/j.molstruc.2003.10.049
(2004)Doi:10.1002/ardp.201200038
(2012)Doi:10.1016/j.molstruc.2009.12.043
(2010)Doi:10.1016/j.tetlet.2010.02.163
(2010)Doi:10.1016/j.jfluchem.2010.11.004
(2011)